+
データを開く
-
基本情報
| 登録情報 | データベース: PDB / ID: 1q9c | ||||||
|---|---|---|---|---|---|---|---|
| タイトル | Crystal Structure of the Histone domain of Son of Sevenless | ||||||
要素 | Son of sevenless protein | ||||||
キーワード | SIGNALING PROTEIN / Histone fold / H2A / H2B | ||||||
| 機能・相同性 | 機能・相同性情報midbrain morphogenesis / regulation of pro-B cell differentiation / vitellogenesis / pericardium morphogenesis / cardiac atrium morphogenesis / heart trabecula morphogenesis / regulation of T cell differentiation in thymus / GTPase complex / Interleukin-15 signaling / positive regulation of small GTPase mediated signal transduction ...midbrain morphogenesis / regulation of pro-B cell differentiation / vitellogenesis / pericardium morphogenesis / cardiac atrium morphogenesis / heart trabecula morphogenesis / regulation of T cell differentiation in thymus / GTPase complex / Interleukin-15 signaling / positive regulation of small GTPase mediated signal transduction / Activation of RAC1 / blood vessel morphogenesis / Signaling by LTK / epidermal growth factor receptor binding / Regulation of KIT signaling / positive regulation of epidermal growth factor receptor signaling pathway / leukocyte migration / NRAGE signals death through JNK / neurotrophin TRK receptor signaling pathway / Fc-epsilon receptor signaling pathway / eyelid development in camera-type eye / GRB2:SOS provides linkage to MAPK signaling for Integrins / roof of mouth development / regulation of T cell proliferation / B cell homeostasis / RET signaling / SOS-mediated signalling / Activated NTRK3 signals through RAS / Activated NTRK2 signals through RAS / fibroblast growth factor receptor signaling pathway / Role of LAT2/NTAL/LAB on calcium mobilization / SHC1 events in ERBB4 signaling / hair follicle development / Interleukin receptor SHC signaling / Signalling to RAS / Signal attenuation / Activated NTRK2 signals through FRS2 and FRS3 / SHC-related events triggered by IGF1R / Schwann cell development / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / SHC-mediated cascade:FGFR2 / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / SHC-mediated cascade:FGFR4 / Erythropoietin activates RAS / SHC-mediated cascade:FGFR1 / Signaling by FGFR4 in disease / FRS-mediated FGFR3 signaling / Signaling by FLT3 ITD and TKD mutants / FRS-mediated FGFR2 signaling / FRS-mediated FGFR4 signaling / FRS-mediated FGFR1 signaling / Signaling by FGFR3 in disease / Tie2 Signaling / Signaling by FGFR2 in disease / RAC1 GTPase cycle / myelination / GRB2 events in EGFR signaling / SHC1 events in EGFR signaling / Signaling by FLT3 fusion proteins / FLT3 Signaling / Signaling by FGFR1 in disease / EGFR Transactivation by Gastrin / FCERI mediated Ca+2 mobilization / NCAM signaling for neurite out-growth / GRB2 events in ERBB2 signaling / Downstream signal transduction / Insulin receptor signalling cascade / insulin-like growth factor receptor signaling pathway / SHC1 events in ERBB2 signaling / GTPase activator activity / axon guidance / Antigen activates B Cell Receptor (BCR) leading to generation of second messengers / Constitutive Signaling by Overexpressed ERBB2 / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / guanyl-nucleotide exchange factor activity / T cell activation / response to ischemia / B cell receptor signaling pathway / FCERI mediated MAPK activation / molecular condensate scaffold activity / Signaling by ERBB2 TMD/JMD mutants / Signaling by SCF-KIT / Constitutive Signaling by EGFRvIII / Signaling by ERBB2 ECD mutants / Signaling by ERBB2 KD Mutants / SH3 domain binding / multicellular organism growth / epidermal growth factor receptor signaling pathway / cytokine-mediated signaling pathway / Signaling by CSF1 (M-CSF) in myeloid cells / insulin receptor signaling pathway / DAP12 signaling / G alpha (12/13) signalling events / Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants / regulation of cell population proliferation / RAF/MAP kinase cascade / Potential therapeutics for SARS / Ras protein signal transduction 類似検索 - 分子機能 | ||||||
| 生物種 | Homo sapiens (ヒト) | ||||||
| 手法 | X線回折 / シンクロトロン / 単波長異常分散 / 解像度: 3.21 Å | ||||||
データ登録者 | Sondermann, H. / Soisson, S.M. / Bar-Sagi, D. / Kuriyan, J. | ||||||
引用 | ジャーナル: Structure / 年: 2003タイトル: Tandem Histone Folds in the Structure of the N-terminal Segment of the Ras Activator Son of Sevenless 著者: Sondermann, H. / Soisson, S.M. / Bar-Sagi, D. / Kuriyan, J. | ||||||
| 履歴 |
| ||||||
| Remark 999 | SEQUENCE THE AUTHORS SEQUENCED THE ORIGINAL DNA, AND CONSISTENTLY FIND AN ALA AT POSITION 145. ...SEQUENCE THE AUTHORS SEQUENCED THE ORIGINAL DNA, AND CONSISTENTLY FIND AN ALA AT POSITION 145. ALSO, THE DENSITY FITS BETTER FOR AN ALA (COMPARED TO VAL). THE AUTHORS STATE THAT IN MOST OF THE SEQUENCES FROM OTHER SPECIES AND ISOFORMS, THIS POSITION IS AN ALA. |
-
構造の表示
| 構造ビューア | 分子: Molmil Jmol/JSmol |
|---|
-
ダウンロードとリンク
-
ダウンロード
| PDBx/mmCIF形式 | 1q9c.cif.gz | 313.4 KB | 表示 | PDBx/mmCIF形式 |
|---|---|---|---|---|
| PDB形式 | pdb1q9c.ent.gz | 260.5 KB | 表示 | PDB形式 |
| PDBx/mmJSON形式 | 1q9c.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
| その他 | その他のダウンロード |
-検証レポート
| 文書・要旨 | 1q9c_validation.pdf.gz | 499 KB | 表示 | wwPDB検証レポート |
|---|---|---|---|---|
| 文書・詳細版 | 1q9c_full_validation.pdf.gz | 549.8 KB | 表示 | |
| XML形式データ | 1q9c_validation.xml.gz | 66.4 KB | 表示 | |
| CIF形式データ | 1q9c_validation.cif.gz | 83.1 KB | 表示 | |
| アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/q9/1q9c ftp://data.pdbj.org/pub/pdb/validation_reports/q9/1q9c | HTTPS FTP |
-関連構造データ
-
リンク
-
集合体
| 登録構造単位 | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | ![]()
| ||||||||
| 2 | ![]()
| ||||||||
| 3 | ![]()
| ||||||||
| 4 | ![]()
| ||||||||
| 5 | ![]()
| ||||||||
| 6 | ![]()
| ||||||||
| 7 | ![]()
| ||||||||
| 8 | ![]()
| ||||||||
| 9 | ![]()
| ||||||||
| 単位格子 |
|
-
要素
| #1: タンパク質 | 分子量: 22190.918 Da / 分子数: 9 / 断片: N-terminal Histone domain / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: SOS1 / プラスミド: pProExHTb / 発現宿主: ![]() Has protein modification | Y | |
|---|
-実験情報
-実験
| 実験 | 手法: X線回折 / 使用した結晶の数: 1 |
|---|
-
試料調製
| 結晶 | マシュー密度: 2.71 Å3/Da / 溶媒含有率: 54.62 % | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 結晶化 | 温度: 293 K / 手法: 蒸気拡散法, ハンギングドロップ法 / pH: 7.5 詳細: PEG3350, L-proline, magnesium acetate, ethanol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K | ||||||||||||||||||||||||||||||
| 結晶化 | *PLUS 手法: 蒸気拡散法, ハンギングドロップ法 | ||||||||||||||||||||||||||||||
| 溶液の組成 | *PLUS
|
-データ収集
| 回折 | 平均測定温度: 100 K |
|---|---|
| 放射光源 | 由来: シンクロトロン / サイト: ALS / ビームライン: 8.2.2 / 波長: 0.9793 Å |
| 検出器 | タイプ: ADSC QUANTUM 4 / 検出器: CCD / 日付: 2002年9月26日 / 詳細: Double-crystal Si(111) |
| 放射 | モノクロメーター: Double-crystal Si(111) / プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
| 放射波長 | 波長: 0.9793 Å / 相対比: 1 |
| 反射 | 解像度: 3.211→19.9 Å / Num. all: 36035 / Num. obs: 35294 / % possible obs: 99.6 % / Observed criterion σ(F): 0 / Observed criterion σ(I): -3 / 冗長度: 7.5 % / Biso Wilson estimate: 68.3 Å2 / Rsym value: 0.066 / Net I/σ(I): 20.1 |
| 反射 シェル | 解像度: 3.21→3.31 Å / Mean I/σ(I) obs: 4 / Rsym value: 0.4 / % possible all: 98.9 |
| 反射 | *PLUS 最高解像度: 3.2 Å / 最低解像度: 99 Å / % possible obs: 99 % / Rmerge(I) obs: 0.066 |
| 反射 シェル | *PLUS % possible obs: 96.9 % / Rmerge(I) obs: 0.365 / Mean I/σ(I) obs: 2.88 |
-
解析
| ソフトウェア |
| |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 精密化 | 構造決定の手法: 単波長異常分散 / 解像度: 3.21→19.9 Å / Rfactor Rfree error: 0.006 / Isotropic thermal model: RESTRAINED / 交差検証法: THROUGHOUT / σ(F): 0
| |||||||||||||||||||||||||
| 溶媒の処理 | 溶媒モデル: FLAT MODEL / Bsol: 15.0817 Å2 / ksol: 0.204227 e/Å3 | |||||||||||||||||||||||||
| 原子変位パラメータ | Biso mean: 82.8 Å2
| |||||||||||||||||||||||||
| Refine analyze | Luzzati coordinate error free: 0.49 Å / Luzzati sigma a free: 0.66 Å | |||||||||||||||||||||||||
| 精密化ステップ | サイクル: LAST / 解像度: 3.21→19.9 Å
| |||||||||||||||||||||||||
| 拘束条件 |
| |||||||||||||||||||||||||
| LS精密化 シェル | 解像度: 3.21→3.41 Å / Rfactor Rfree error: 0.018 / Total num. of bins used: 6
| |||||||||||||||||||||||||
| Xplor file |
| |||||||||||||||||||||||||
| 精密化 | *PLUS 最低解像度: 20 Å | |||||||||||||||||||||||||
| 溶媒の処理 | *PLUS | |||||||||||||||||||||||||
| 原子変位パラメータ | *PLUS | |||||||||||||||||||||||||
| 拘束条件 | *PLUS
|
ムービー
コントローラー
万見について




Homo sapiens (ヒト)
X線回折
引用









PDBj



































